
Edwards Lifesciences (EW) Stock Forecast & Price Target
Edwards Lifesciences (EW) Analyst Ratings
Bulls say
Edwards Lifesciences is a high-performing company, with a strong focus on growth, a diverse range of products, and a solid financial outlook. The company's strong performance and growth potential are supported by increasing sales projections, a robust product pipeline, and a focus on expanding into international markets. Risks such as potential commercial and regulatory challenges should be carefully monitored, but overall, Edwards Lifesciences presents a positive investment opportunity for those seeking exposure to the medical device industry.
Bears say
Edwards Lifesciences is a global leader in advanced medical devices for structural heart diseases with significant exposure and strong sales outside of the US. However, with increasing competition and pricing pressure in key markets, coupled with limited growth potential in its core products, it is likely to face challenges in maintaining its current growth trajectory and profitability. As a result, the high valuation multiples may not be sustainable in the long-term, leading to a negative outlook for the stock.
This aggregate rating is based on analysts' research of Edwards Lifesciences and is not a guaranteed prediction by Public.com or investment advice.
Edwards Lifesciences (EW) Analyst Forecast & Price Prediction
Start investing in Edwards Lifesciences (EW)
Order type
Buy in
Order amount
Est. shares
0 shares